The Supreme Court is gearing up to enter a long-running debate on whether a person who sells the patent rights to an invention can later turn around and attack the patent’s validity.

The justices on Friday granted certiorari in Minerva Surgical v. Hologic, putting patent law’s doctrine of assignor estoppel squarely before the court. Some academics and a few Federal Circuit judges have been calling for a rethink for a number of years, though patent owners argue that eliminating it would work a fundamental unfairness.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]